Raymond James & Associates’s PolyPid PYPD Stock Holding History

Raymond James & Associates’s Portfolio PYPD Stock Details PYPD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-350	Closed	-$49K	–	4107
2022 Q2	$49K	Sell	350 -110	-24%	-$16.5K	﹤0.01%	3790
2022 Q1	$75K	Buy	460 +2	+0.4%	+$303	﹤0.01%	3872
2021 Q4	$79K	Sell	458 -87	-16%	-$18.4K	﹤0.01%	3899
2021 Q3	$127K	Buy	545 +13	+2%	+$3.17K	﹤0.01%	3789
2021 Q2	$144K	Buy	532 +53	+11%	+$14.7K	﹤0.01%	3767
2021 Q1	$132K	Sell	479 -295	-38%	-$96.1K	﹤0.01%	3724
2020 Q4	$231K	Buy	+774	New	+$247K	﹤0.01%	3290

Other funds holding PYPD

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

JWM

JFG Wealth Management Denver, Colorado $511M AUM 14.9% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

XR Securities Chicago, Illinois $5.35M AUM 26.1% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Raymond James & Associates's PYPD Position: Q3 2022 in Review

Raymond James & Associates sold out of PolyPid (PYPD) in Q3 2022, closing a stake of 350 shares — an estimated $49K sold.

Raymond James & Associates first reported a position in PYPD in Q4 2020 and held it in 7 quarters. The position peaked at $231K in Q4 2020. 17 funds tracked by Wall St. Rank hold PYPD as of Q3 2022.

Raymond James & Associates reported no remaining PolyPid position as of Q3 2022 after selling out during the quarter.
Raymond James & Associates sold 350 PolyPid shares in Q3 2022, an estimated $49K.
Raymond James & Associates first reported a position in PolyPid in Q4 2020 and held it in 7 quarters.
Raymond James & Associates's PolyPid position peaked at $231K in Q4 2020.
17 funds tracked by Wall St. Rank held PolyPid as of Q3 2022.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.